LY3471851
17240
Phase 1 small_molecule completed
Quick answer
LY3471851 for Dermatitis, Atopic is a Phase 1 program (small_molecule) at NEKTAR THERAPEUTICS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEKTAR THERAPEUTICS
- Indication
- Dermatitis, Atopic
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed